About us
Norwegian Cancer Genomics Consortium (NCGC) consists of clinicians and specialised cancer research groups, situated at the Norwegian University Hospitals. The participants collaborate on two large research projects, focused on cancer genomics. The projects, which have received 75 M NOK in funding from the Norwegian Research Council, aim to establish new clinical practises for cancer treatment. The projects are led by the associated group leaders, Tom Dønnem (UNN), Bjørn Tore Gjertsen (HUS), Jutta Heix (Oslo Cancer Cluster), Harald Holte (OUS), Eivind Hovig (OUS), Ragnhild Lothe (OUS), Per Eystein Lønning (HUS), Leonardo Meza-Zepeda (OUS), Ola Myklebost (OUS), Sissel Rogne (Bioteknologirådet), Ole Morten Seternes (UiT), Jan Helge Solbakk (UiO, vara Sissel Rogne), Giske Ursin (KR), Anders Waage (St Olav). Eyrun Thune is the coordinator.
Contacts
Ola Myklebost
Professor, Project leader
+47 5558 4565
Liv Cecilie Vestrheim Thomsen
Co-ordinator
+47 909 35 449
The Governing Board
Erlend B Smeland
Professor, Forskningsdriektør OUS, – Styreleder
Jónas Einarsson
Direktør Radiumhospitalets forskningsstiftelse
Anne Sameline Grimsgaard
Professor, Forskningsdekan UNN/UiT
Bjørn Gustafsson
Professor, Forskningsdekan StOlav/NTNU
Tove Flem Jacobsen
VP Science & Regulatory at Aker BioMarine Antarctic
Edvin W Johannesen
Seniorrådgiver – Forskningsadministrasjon UiO
Olav Mella
Professor, Avdelingssjef Haukeland/UiB
Knut Martin Torgersen
Medisinsk rådgiver Pfizer